Perspective Therapeutics, Inc. CATX

Set alert

0.88 USD -0.16 (-15.38%)

At closeNov 3, 2026, 4:00 PM EST

0.90 +0.02 +2.00%

After hours · Nov 3, 4:00 PM ET

0.8759 Day range 1.07

0.8759 52-week range 6.16

Held by insiders 20.46%

Held by institutions 81.43%

Float held by institutions 102.37%

Institutions 174

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	8.14%	5,504,822	17.29M	Sep 29, 2024
Janus Henderson Group PLC	7.10%	4,799,352	15.07M	Sep 29, 2024
Blackrock Inc.	5.98%	4,039,974	12.69M	Sep 29, 2024
Avidity Partners Management, LP	5.10%	3,444,002	10.81M	Sep 29, 2024
Commodore Capital Lp	4.96%	3,350,000	10.52M	Sep 29, 2024
Vanguard Group Inc	4.55%	3,076,941	9.66M	Sep 29, 2024

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Vanguard Total Stock Market Index Fund	2.50%	1,692,046	5.31M	Sep 29, 2024
iShares Russell 2000 ETF	2.06%	1,393,938	4.38M	Oct 30, 2024
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF	1.72%	1,162,536	3.65M	Sep 29, 2024
Fidelity Advisor Biotechnology Fund	1.56%	1,052,713	3.31M	Oct 30, 2024
Janus Henderson Global Life Sciences Fund	1.41%	953,832	3.00M	Sep 29, 2024
Vanguard Extended Market Index Fund	1.19%	806,419	2.53M	Sep 29, 2024

CATX insiders
Insider	Relation	Latest transaction	Date	Shares held
AUSTIN MARK JOHN	Chief Financial Officer	Conversion of Exercise of derivative security	Apr 22, 2024	84,030
HENSON HEIDI	Director	Purchase	Dec 3, 2024	0
HUNT JONATHAN ROBERT	Chief Financial Officer	Purchase	Nov 24, 2024	48,800
LANTHEUS ALPHA THERAPY, LLC	Beneficial Owner of more than 10% of a Class of Security	Purchase	Mar 5, 2024	0
PUHLMANN MARKUS	Officer	Purchase	Jan 23, 2024	1,375,420
SPOOR JOHAN M	Chief Executive Officer	Purchase	Dec 3, 2024	55,257

Held by funds